| Cytokine signaling in multiple sclerosis and its therapeutic applications P Palle, KL Monaghan, SM Milne, ECK Wan Medical sciences 5 (4), 23, 2017 | 98 | 2017 |
| T cell-specific inactivation of mouse CD2 by CRISPR/Cas9 J Beil-Wagner, G Dössinger, K Schober, J Vom Berg, A Tresch, M Grandl, ... Scientific reports 6 (1), 21377, 2016 | 21 | 2016 |
| Bone marrow chimeras—a vital tool in basic and translational research FM Ferreira, P Palle, J Vom Berg, P Prajwal, JD Laman, T Buch Journal of Molecular Medicine 97, 889-896, 2019 | 20 | 2019 |
| The more the merrier? Scoring, statistics and animal welfare in experimental autoimmune encephalomyelitis P Palle, FM Ferreira, A Methner, T Buch Laboratory animals 50 (6), 427-432, 2016 | 20 | 2016 |
| Mature oligodendrocytes actively increase in vivo cytoskeletal plasticity following CNS damage G Locatelli, A Baggiolini, B Schreiner, P Palle, A Waisman, B Becher, ... Journal of neuroinflammation 12, 1-12, 2015 | 10 | 2015 |
| STAT1 signaling protects self-reactive T cells from control by innate cells during neuroinflammation CA Arbelaez, P Palle, J Charaix, E Bettelli JCI insight 7 (12), 2022 | 8 | 2022 |
| Cutting edge: Dock8 regulates a subset of dendritic cells that is critical for the development of experimental autoimmune encephalomyelitis A Weliwitigoda, P Palle, M Gessner, NW Hubbard, M Oukka, E Bettelli The Journal of Immunology 207 (10), 2417-2422, 2021 | 1 | 2021 |
| Triggers of anti-CNS autoimmunity in the mouse model of Multiple Sclerosis P Palle Technische Universität München, 2017 | | 2017 |
